13.02

3.42% 0.43

After Hours: 12.97 -0.05 -0.38%

Personalis Inc (PSNL)

Overview News Price History Option Chain Financials Discussions Forecast

Personalis Inc stock is traded at $13.02, with a volume of 8.35M. It is up +3.42% in the last 24 hours and up +45.64% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Previous Close:

$12.59

Open:

$12.5

24h Volume:

8.35M

Relative Volume:

3.22

Market Cap:

$1.36B

Revenue:

$64.52M

Net Income/Loss:

$-95.55M

P/E Ratio:

-12.80

EPS:

-1.0169

Net Cash Flow:

$-84.65M

1W Performance:

+23.53%

1M Performance:

+45.64%

6M Performance:

+59.95%

1Y Performance:

+104.40%

1-Day Range:

$12.26

$13.37

1-Week Range:

$9.65

$13.37

52-Week Range:

$3.84

$13.37

Personalis Inc Stock (PSNL) Company Profile

Name

Personalis Inc

Sector

Healthcare (1096)

Industry

Diagnostics & Research (48)

Phone

650-752-1300

Address

6600 DUMBARTON CIRCLE, FREMONT, CA

Employee

260

Twitter

@PersonalisInc

Next Earnings Date

2026-08-04

Latest SEC Filings

PSNL's Discussions on Twitter

Compare PSNL vs TMO, DHR, IDXX, A, NTRA

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PSNL Personalis Inc	13.02	1.32B	64.52M	-95.55M	-84.65M	-1.0169
TMO Thermo Fisher Scientific Inc	513.03	187.95B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	196.19	136.75B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	551.50	43.78B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	136.01	38.27B	7.23B	1.41B	1.09B	4.979
NTRA Natera Inc	261.91	37.34B	2.50B	-226.32M	71.51M	-1.6412

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
May-15-25	Initiated	Guggenheim	Buy
Mar-17-25	Initiated	Craig Hallum	Buy
Feb-06-23	Upgrade	Needham	Hold → Buy
Jan-07-22	Upgrade	BofA Securities	Neutral → Buy
Nov-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-03-21	Downgrade	Needham	Buy → Hold
Oct-15-21	Resumed	Cowen	Outperform
Sep-20-21	Reiterated	Needham	Buy
May-06-21	Upgrade	Oppenheimer	Perform → Outperform
Jan-28-21	Initiated	Truist	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Nov-12-20	Reiterated	Needham	Buy
Nov-06-20	Downgrade	Oppenheimer	Outperform → Perform
Oct-19-20	Initiated	Citigroup	Buy
Oct-08-20	Initiated	BTIG Research	Buy
Aug-27-20	Initiated	H.C. Wainwright	Buy
Aug-18-20	Initiated	Needham	Buy
Sep-26-19	Upgrade	BofA/Merrill	Neutral → Buy
Jul-15-19	Initiated	BofA/Merrill	Neutral
Jul-15-19	Initiated	Cowen	Outperform
Jul-15-19	Initiated	Morgan Stanley	Overweight
Jul-15-19	Initiated	Oppenheimer	Outperform

View All

Personalis Inc Stock (PSNL) Latest News

Jun 26, 2026

Personalis CEO Christopher Hall sells $1.31m in company stock By Investing.com - Investing.com Australia

Jun 26, 2026

Personalis CFO Aaron Tachibana sells $675,488 in company stock - Investing.com

Jun 26, 2026

Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com UK

Jun 26, 2026

Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares - Stock Titan

Jun 26, 2026

Personalis (PSNL) CEO sells 100K shares after exercising options - Stock Titan

Jun 26, 2026

Form 144 Personalis For: 26 June By Investing.com - Investing.com Canada

Jun 26, 2026

PSNL: Form 144 lists 51,251 shares to be sold; prior 10b5-1 sales noted - Stock Titan

Jun 26, 2026

Broker files Form 144 as Christopher Hall sells 100,000 PSNL shares (PSNL) - Stock Titan

Jun 26, 2026

Personalis stock hits 52-week high at 12.53 USD By Investing.com - Investing.com South Africa

Jun 25, 2026

Personalis stock hits 52-week high at 12.53 USD - Investing.com

Jun 25, 2026

Jun 24, 2026